News

  • Using cancer data to improve performance and reduce delays

    By Donna Smith, Director of Strategic Solutions, Insource Cancer care is one of Scotland’s most urgent health system challenges and alarmingly 1 in 2 patients will have a cancer diagnosis in their lifetime. Thousands of people each year experience the fear and uncertainty whilst waiting for a cancer diagnosis. For me, the importance of timely [...]

  • Guardant Health acquires MetaSight in US$150m deal

    Guardant Health has acquired Israeli diagnostics startup MetaSight in a deal valued at up to US$150m, highlighting growing international investment in Israel’s health technology sector. The agreement includes US$60m in upfront cash, before standard deductions, along with up to US$90m in contingent payments tied to future performance milestones. The acquisition is expected to accelerate the [...]

  • Hims & Hers to acquire Eucalyptus for US$1.15bn

    Hims & Hers has agreed to buy Eucalyptus in a deal worth up to US$1.15bn, expanding its international digital health reach beyond the US. Eucalyptus, founded in 2019, operates consumer health brands including Juniper and Pilot across Australia, the UK, Germany, Japan and Canada. The company says it has served more than 775,000 customers and [...]

  • Sanofi backs Altesa US$75m rhinovirus series B

    Sanofi has backed Altesa BioSciences in a US$75m series B round for the rhinovirus-focused biotech led by former acting FDA commissioner Brett Giroir. The funding will mainly support a phase 2b study, a mid-stage clinical trial, of vapendavir, an oral antiviral pill for patients with chronic obstructive pulmonary disease (COPD), a long-term lung condition that [...]

  • 4.2m eye health research hub set for north east

    A new £4.2m research institute in North East England will use routine eye scans to improve eye health and spot early signs of serious illness. The Northern Ophthalmic Research and Innovation Institute (NORI) brings together university experts, the NHS, local authorities and industry to use routine eye scans to spot early signs of serious illness. [...]

  • Sleep trackers flag depression relapse early

    Sleep trackers may spot depression relapse weeks before symptoms return, a study of 93 adults with remitted major depressive disorder suggests. Researchers followed people whose symptoms had eased but who remained at risk of recurrence. Participants wore research-grade wrist actigraphy devices, which track movement to estimate sleep and activity, for up to two years, generating [...]

  • GE HealthCare expands US$35m AI ultrasound deal

    GE HealthCare has secured a US$35m BARDA contract expansion for AI ultrasound tools intended to help non-expert users assess trauma patients. The deal with the US Biomedical Advanced Research and Development Authority (BARDA) builds on a US$44m agreement struck in 2023 to fund tools for diagnosing patients in mass casualty incidents. Under the original deal, [...]

  • EIR targets US$17.1m in NYSE listing

    Preclinical eye-disease biotech EIR Biopharma aims to raise up to US$17.1m via a NYSE listing. San Francisco-based EIR plans to offer 3.75m shares priced between US$4 and US$5, according to a Securities and Exchange Commission filing. At the midpoint, it expects US$14.9m in net proceeds. If underwriters take up their option for an extra 562,500 [...]

  • New £20m tech grants aim to reduce drug and alcohol deaths

    The UK is offering £20m in addiction tech grants to cut harm and deaths linked to drug and alcohol addiction. Delivered through Innovate UK, the funding sits within the government’s Addiction Healthcare Goals programme and will support new medicines, medical devices, wearables, virtual reality therapies, treatment apps and AI-enabled tools. Around 15,000 people die each [...]

  • Matresa secures £315,000 for preventative maternal health platform

    Matresa has raised £315,000 in pre-seed funding for a preventative maternal health platform offering continuous support from pregnancy through early parenthood. Founded by former paediatric intensive care nurse Mari-Carmen Sanchez-Morris, the London-based startup is building a clinical-grade screening and diagnostics platform intended to shift maternal care from reactive to preventative. It will offer personalised support [...]